Skip Ribbon Commands
Skip to main content

Cellular Immunotherapy for Cancer

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   |   About CIBMTR   |   Who We Are   |   Committees   |   Working Committees   |   Cellular Immunotherapy for Cancer
  • Print
  • Share

Cellular Immunotherapy for Cancer

The Cellular Immunotherapy for Cancer Working Committee provides scientific oversight for studies related to the utilization and outcomes after CAR-T Cell therapies and other cellular immunotherapies. Studies that focus on specific outcomes, predictors of outcomes, and utilization of CAR-T Cells should be submitted to this committee.

Studies and Publications
View planned, in progress, and completed studies and publications for this committee.


CIBMTR Working Committees meet annually during the Tandem Meetings I Transplantation and Cellular Therapy Meetings of ASTCT & CIBMTR. View meeting materials for this committee.

For questions about this committee, or to get involved, please contact:

Committee Leadership

Peiman Hematti, MDUniversity of Wisconsin Hospital and Clinics, Madison, WI

​Cameron Turtle, MBBS, PhD

​Fred Hutchinson Cancer Research Center, Seattle, WA

Sairah Ahmed, MD
​M.D. Anderson Cancer Center, Houston, TX


CIBMTR Scientific Director
Marcelo Pasquini, MD, MS Froedtert Hospital, Medical College of Wisconsin, CIBMTR MCW


assistant Scientific Director
Amy Moskop, MD, MSChildrens' Wisconsin, Medical College of Wisconsin, CIBMTR MCW

Statistical Director
Soyoung Kim, PhD
Medical College of Wisconsin, CIBMTR MCW


CIBMTR Statistician
Matthew Bye, MPHMedical College of Wisconsin, CIBMTR MCW

Last Updated: 9/20/2022 2:11 PM